Mitchell H. Gail
American physician-scientist and biostatistician
Mitchell H. Gail's AcademicInfluence.com Rankings
Download Badge
Philosophy Mathematics
Mitchell H. Gail's Degrees
- Masters Medicine University of Pennsylvania
Why Is Mitchell H. Gail Influential?
(Suggest an Edit or Addition)According to Wikipedia, Mitchell H. Gail is an American physician-scientist and biostatistician. He is a distinguished investigator at the National Cancer Institute. Life Gail completed a M.D. from Harvard Medical School in 1968 and a Ph.D. in statistics from George Washington University in 1977. He joined the National Cancer Institute in 1969, and served as chief of the biostatistics branch from 1994 to 2008. Gail is a Fellow and former President of the American Statistical Association, a Fellow of the American Association for the Advancement of Science, an elected member of the American Society for Clinical Investigation, and an elected member of the National Academy of Medicine. He has received the Spiegelman Gold Medal for Health Statistics, the Snedecor Award for applied statistical research, the Howard Temin Award for AIDS Research, the NIH Director's Award, the Public Health Service Distinguished Service Medal, the Nathan Mantel Lifetime Achievement Award, the NIH Robert S. Gordon, Jr. Lecture in Epidemiology, and the AACR - American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention. He was named an NIH Distinguished Investigator in 2019.
Mitchell H. Gail's Published Works
Published Works
- Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. (1989) (3091)
- Excess deaths associated with underweight, overweight, and obesity. (2005) (1998)
- Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. (1993) (1755)
- Cause-specific excess deaths associated with underweight, overweight, and obesity. (2007) (1536)
- Spectrum of AIDS-associated malignant disorders (1998) (721)
- Population attributable risks of esophageal and gastric cancers. (2003) (714)
- Validation studies for models projecting the risk of invasive and total breast cancer incidence. (1999) (704)
- Cancer burden in the HIV-infected population in the United States. (2011) (677)
- Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. (1999) (666)
- Estimation of effect size distribution from genome-wide association studies and implications for future discoveries (2010) (651)
- Testing for qualitative interactions between treatment effects and patient subsets. (1985) (621)
- Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates (1984) (612)
- Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. (2001) (560)
- Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. (2012) (544)
- A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma (2010) (469)
- A Prospective Study of Red and Processed Meat Intake in Relation to Cancer Risk (2007) (451)
- Performance of common genetic variants in breast-cancer risk models. (2010) (430)
- Randomized clinical trials. Perspectives on some recent ideas. (1976) (424)
- Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. (1986) (419)
- Excess Deaths Associated With Underweight, Overweight, and Obesity: An Evaluation of Potential Bias. (2005) (415)
- Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. (1995) (407)
- Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. (2001) (406)
- Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. (2006) (406)
- Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. (2012) (403)
- Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. (2005) (399)
- Biased selection of controls for case-control analyses of cohort studies. (1984) (393)
- A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data (1989) (366)
- Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. (2006) (348)
- The locomotion of mouse fibroblasts in tissue culture. (1970) (340)
- Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study (2012) (316)
- Early menopause in long-term survivors of cancer during adolescence (1992) (312)
- A Method for Obtaining Short-Term Projections and Lower Bounds on the Size of the AIDS Epidemic (1988) (308)
- Projecting individualized absolute invasive breast cancer risk in African American women. (2007) (306)
- Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. (1987) (302)
- Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. (2009) (293)
- Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. (2000) (269)
- Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group (1984) (265)
- Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. (2003) (253)
- AIDS Epidemiology: A Quantitative Approach (1994) (253)
- Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants (2011) (252)
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. (1981) (252)
- Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. (2016) (250)
- Cancer risk prediction models: a workshop on development, evaluation, and application. (2005) (242)
- On design considerations and randomization-based inference for community intervention trials. (1996) (239)
- Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. (1987) (234)
- On criteria for evaluating models of absolute risk. (2005) (232)
- Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. (2008) (231)
- A review and critique of some models used in competing risk analysis. (1975) (226)
- Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China (2002) (225)
- Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features (2016) (223)
- Colorectal cancer risk prediction tool for white men and women without known susceptibility. (2009) (218)
- Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. (2015) (216)
- Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. (2005) (216)
- Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. (1995) (215)
- Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1 (1999) (213)
- Estimates of absolute cause-specific risk in cohort studies. (1990) (207)
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. (1986) (205)
- An analysis of comparative carcinogenesis experiments based on multiple times to tumor. (1980) (199)
- Encyclopedia of Epidemiologic Methods (2002) (196)
- The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop (2009) (196)
- A Scale‐Free Goodness‐Of‐Fit Test for the Exponential Distribution Based on the Gini Statistic (1978) (195)
- Estrogen metabolism and risk of breast cancer in postmenopausal women. (2012) (191)
- Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. (2014) (187)
- MINIMUM SIZE OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) EPIDEMIC IN THE UNITED STATES (1986) (184)
- Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts (2018) (181)
- Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. (1990) (177)
- Familial aggregation of Hodgkin lymphoma and related tumors (2004) (175)
- Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. (1988) (170)
- Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. (2011) (170)
- Haplotype analysis in population genetics and association studies. (2003) (169)
- Likelihood calculations for matched case-control studies and survival studies with tied death times (1981) (168)
- Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. (2011) (156)
- Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer (1999) (155)
- Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. (2002) (149)
- On meta-analytic assessment of surrogate outcomes. (2000) (147)
- The promise and peril of surrogate end points in cancer research (2002) (142)
- On power and sample size for studying features of the relative odds of disease. (1990) (141)
- Risk Prediction for Breast, Endometrial, and Ovarian Cancer in White Women Aged 50 y or Older: Derivation and Validation from Population-Based Cohort Studies (2013) (137)
- Estrogen replacement therapy and breast cancer survival in a large screening study. (1999) (136)
- Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations (2014) (133)
- Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. (1991) (133)
- Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. (2014) (132)
- Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts (2010) (131)
- Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). (1992) (129)
- Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. (2009) (127)
- Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer (2011) (127)
- Effect of colcemid on fibroblast motility. (1971) (127)
- Tests for no treatment e?ect in randomized clinical trials (1988) (127)
- How many controls? (1976) (125)
- Biases in prevalent cohorts. (1987) (124)
- Cell-substrate adhesivity. A determinant of cell motility. (1972) (122)
- Validating and improving models for projecting the absolute risk of breast cancer. (2001) (121)
- Antiretroviral Therapy for Adult HIV-lnfected Patients: Recommendations From a State-of-the-Art Conference (1993) (121)
- Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. (2009) (120)
- Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study (2016) (120)
- Geographic variation in mortality from breast cancer among white women in the United States. (1995) (120)
- Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity (2008) (119)
- Transmission of HTLV-I and HIV among homosexual men in Trinidad. (1987) (119)
- Association between Upper Digestive Tract Microbiota and Cancer-Predisposing States in the Esophagus and Stomach (2014) (119)
- Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial (2019) (117)
- Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors. (2002) (111)
- The effect of cigarette smoking on the oral and nasal microbiota (2017) (109)
- Does cardiac transplantation prolong life? A reassessment. (1972) (109)
- The prevalent cohort study and the acquired immunodeficiency syndrome. (1987) (108)
- Therapy may explain recent deficits in AIDS incidence. (1990) (108)
- Confirmation of family cancer history reported in a population-based survey. (2011) (104)
- A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study (2008) (104)
- Application of DNA fingerprints for cell-line individualization. (1990) (101)
- Evaluating serial cancer marker studies in patients at risk of recurrent disease. (1981) (100)
- Impact of smoking and preexisting illness on estimates of the fractions of deaths associated with underweight, overweight, and obesity in the US population. (2007) (100)
- Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. (2006) (98)
- Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. (2013) (98)
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies (2018) (97)
- A Scale-Free Goodness-of-Fit Test for the Exponential Distribution Based on the Lorenz Curve (1978) (97)
- Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. (1998) (97)
- Counting the Number of r×c Contingency Tables with Fixed Margins (1977) (96)
- Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group. (1981) (95)
- More on "Biased selection of controls for case-control analyses of cohort studies". (1986) (95)
- Comparing breast cancer risk assessment models. (2010) (93)
- Diet and Stomach Cancer Risk in Warsaw, Poland (2004) (92)
- Case-Control Studies With Errors in Covariates (1993) (91)
- Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer. (1998) (91)
- Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count. (1989) (90)
- Risk factor modification and projections of absolute breast cancer risk. (2011) (88)
- Nonparametric Estimation for a Scale-Change with Censored Observations (1983) (84)
- Cancer in Korean war navy technicians: mortality survey after 40 years. (2002) (83)
- Methods for projecting course of acquired immunodeficiency syndrome epidemic. (1988) (83)
- Alternative variance and efficiency calculations for the case-cohort design (1989) (83)
- Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer. (1987) (82)
- Increasing incidence of non-Hodgkin's lymphoma. (1993) (82)
- Graphs to estimate an individualized risk of breast cancer. (1996) (81)
- A Delta Method for Implicitly Defined Random Variables (1989) (80)
- Postdiagnosis Diet Quality Is Inversely Related to a Biomarker of Inflammation among Breast Cancer Survivors (2010) (79)
- Personalized estimates of breast cancer risk in clinical practice and public health (2011) (79)
- Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions (2018) (77)
- Epidemiology and Biostatistics Program of the National Cancer Institute (1994) (76)
- Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. (1997) (75)
- Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. (2017) (75)
- Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments (2005) (75)
- Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. (1998) (75)
- Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. (2010) (73)
- Comparison of four tests for equality of survival curves in the presence of stratification and censoring (1979) (73)
- Risk-based recommendations for mammographic screening for women in their forties. (1998) (72)
- A Reminder of the Fallibility of the Wald Statistic (1996) (71)
- Backcalculation of flexible linear models of the human immunodeficiency virus infection curve. (1991) (71)
- Validation of a model of lung cancer risk prediction among smokers. (2006) (71)
- Lung cancer prognosis before and after recurrence in a population-based setting. (2015) (70)
- Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. (2013) (68)
- Density inhibition of motility in 3T3 fibroblasts and their SV40 transformants. (1971) (68)
- Designing studies to estimate the penetrance of an identified autosomal dominant mutation: Cohort, case‐control, and genotyped‐proband designs (1999) (68)
- Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial (2018) (68)
- A generalization of the one-sided two-sample Kolmogorov-Smirnov statistic for evaluating diagnostic tests. (1976) (67)
- Mendelian Randomization: How It Can—and Cannot—Help Confirm Causal Relations between Nutrition and Cancer (2009) (67)
- Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status. (2015) (66)
- A comparison of the power of two tests for qualitative interactions. (1993) (66)
- The Analysis of Heterogeneity for Indirect Standardized Mortality Ratios (1978) (65)
- PHYSICOCHEMICAL DIFFERENCES BETWEEN FRAGMENTS OF PLASMA MEMBRANE AND ENDOPLASMIC RETICULUM (1966) (65)
- Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. (2000) (64)
- Blood type and family cancer history in relation to precancerous gastric lesions. (2000) (64)
- Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. (1990) (64)
- Precancerous lesions in two counties of China with contrasting gastric cancer risk. (1998) (64)
- Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. (1995) (63)
- Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. (1988) (63)
- Methods of inference for estimates of absolute risk derived from population-based case-control studies. (1995) (63)
- Increasing breast cancer incidence in China: the numbers add up. (2008) (63)
- Power Computations for Designing Comparative Poisson Trials (1974) (62)
- National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. (1991) (62)
- Beyond recreational physical activity: examining occupational and household activity, transportation activity, and sedentary behavior in relation to postmenopausal breast cancer risk. (2010) (62)
- Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment. (1980) (60)
- Comparative validation of breast cancer risk prediction models and projections for future risk stratification (2018) (60)
- Estimating HIV prevalence and projecting AIDS incidence in the United States: a model that accounts for therapy and changes in the surveillance definition of AIDS. (1992) (60)
- Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions (2007) (60)
- Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women. (2016) (59)
- Critical Values for the One-Sided Two-Sample Kolmogorov-Smirnov Statistic (1976) (58)
- No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. (2002) (58)
- The determination of sample sizes for use with the exact conditional test in 2 x 2 comparative trials. (1973) (58)
- Procaine inhibition of fibroblast motility and proliferation. (1972) (57)
- Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial. (2020) (54)
- Two Approaches for Estimating Disease Prevalence from Population‐Based Registries of Incidence and Total Mortality (1999) (54)
- Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. (1989) (54)
- Variance Calculations for Direct Adjusted Survival Curves, with Applications to Testing for No Treatment Effect (1986) (53)
- Reproducibility studies and interlaboratory concordance for androgen assays in female plasma. (2000) (53)
- Use of logrank tests and group sequential methods at fixed calendar times. (1985) (52)
- Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994. (1992) (51)
- On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection. (1990) (51)
- Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. (2009) (49)
- A calcium requirement for fibroblast motility and prolifertion. (1973) (49)
- Simulation Studies on Increments of the Two-Sample Logrank Score Test for Survival Time Data, with Application to Group Sequential Boundaries (1982) (49)
- Sample size calculations for population‐ and family‐based case‐control association studies on marker genotypes (2003) (49)
- Association of Fecal Microbial Diversity and Taxonomy with Selected Enzymatic Functions (2012) (48)
- Indirect corrections for confounding under multiplicative and additive risk models. (1988) (48)
- Prevalence of Hepatitis C Virus Infection and Risk for Hepatocellular Carcinoma and Non‐Hodgkin Lymphoma in AIDS (2002) (48)
- Inference for covariates that accounts for ascertainment and random genetic effects in family studies (2001) (48)
- A Randomized Comparison of the Effects of Adjuvant Therapy on Resected Stages II and III Non‐small Cell Carcinoma of the Lung (1985) (48)
- Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation (2013) (47)
- Radiation-induced thyroid neoplasms: evidence for familial susceptibility factors. (1988) (46)
- Absolute Risk: Methods and Applications in Clinical Management and Public Health (2017) (45)
- Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women (2017) (44)
- Kin-cohort designs for gene characterization. (1999) (43)
- Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences (2012) (43)
- Backcalculation of the number with human immunodeficiency virus infection in the United States. (1991) (42)
- Detection of gastric carcinoma‐associated MG7‐Ag by serum immuno‐PCR assay in a high‐risk Chinese population, with implication for screening (2010) (42)
- A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. (2006) (42)
- Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins (2012) (41)
- Probability of detecting disease-associated single nucleotide polymorphisms in case-control genome-wide association studies. (2007) (40)
- Testing for interaction in an I×J×K contingency table (1977) (40)
- Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone. (1996) (39)
- Validation studies on a model for breast cancer risk. (1994) (39)
- Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. (2012) (38)
- Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers. (2007) (37)
- Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening (2018) (37)
- The Effect of Pooling Across Strata in Perfectly Balanced Studies (1988) (37)
- A molecular approach to the identification and individualization of human and animal cells in culture: Isozyme and allozyme genetic signatures (1980) (37)
- Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer (2010) (37)
- Applicability of sample size calculations based on a comparison of proportions for use with the logrank test. (1985) (36)
- The effect of vitamin and mineral supplementation on esophageal cytology: Results from the linxian dysplasia trial (1994) (36)
- Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. N. E. Breslow and N. E. Day, Oxford University Press for International Agency for Research on Cancer, 1987. No of pages: xii + 406. Price: £30 (1989) (36)
- Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group. (1988) (36)
- Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. (2020) (36)
- Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study (2014) (36)
- Effects of cluster sampling on epidemiologic analysis in population-based case-control studies. (1989) (35)
- Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial (2018) (34)
- Five-Year and Lifetime Risk of Breast Cancer among U.S. Subpopulations: Implications for Magnetic Resonance Imaging Screening (2010) (34)
- The determination of sample sizes for trials involving several independent 2x2 tables. (1973) (34)
- Association between tobacco use and the upper gastrointestinal microbiome among Chinese men (2015) (34)
- Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium (2002) (33)
- Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. (1999) (33)
- Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. (1986) (33)
- A bibliography and comments on the use of statistical models in epidemiology in the 1980s. (1991) (32)
- Evaluating breast cancer risk projections for Hispanic women (2012) (31)
- Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population (2005) (31)
- Correlative genetic variation in natural populations of cats, mice and men (1980) (31)
- On Combining Data From Genome-Wide Association Studies to Discover Disease-Associated SNPs (2009) (31)
- Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study (2014) (31)
- Uncertainty in estimates of HIV prevalence derived by backcalculation. (1990) (30)
- Absolute risk models for subtypes of breast cancer. (2007) (30)
- Twenty-five years of breast cancer risk models and their applications. (2015) (30)
- Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival (2018) (30)
- Sample size and power for case-control studies when exposures are continuous. (1988) (30)
- Cytochalasin effects on BALB-3T3 fibroblasts: dose-dependent, reversible alteration of motility and cytoplasmic cleavage. (1971) (29)
- Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial. (2020) (29)
- The efficiency of the matched-pairs design of the Community Intervention Trial for Smoking Cessation (COMMIT). (1997) (29)
- A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions. (2006) (29)
- Disease prevention models of voluntary confidential screening for human immunodeficiency virus (HIV). (1989) (29)
- Gail model and breast cancer (2000) (29)
- Statistics in Action (1996) (29)
- Calibration and seasonal adjustment for matched case–control studies of vitamin D and cancer (2016) (28)
- The Importance of Test Positive Predictive Value in Ovarian Cancer Screening (2008) (28)
- Comments on ‘Choice of time scale and its effect on significance of predictors in longitudinal studies’ by Michael J. Pencina, Martin G. Larson and Ralph B. D'Agostino, Statistics in Medicine 2007; 26:1343–1359 (2009) (28)
- Using cases to strengthen inference on the association between single nucleotide polymorphisms and a secondary phenotype in genome‐wide association studies (2010) (28)
- Secular stability and reliability of measurements of the percentage of dense tissue on mammograms. (2003) (28)
- Strategies for Developing Prediction Models From Genome‐Wide Association Studies (2013) (27)
- The Minimum Size of the AIDS Epidemic in the United States (1986) (27)
- Time lapse studies on the motility of fibroblasts in tissue culture. (2008) (26)
- Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. (1992) (26)
- Estimation of attributable number of deaths and standard errors from simple and complex sampled cohorts (2007) (26)
- Prenatal diethylstilbestrol exposure and cancer risk in women (2019) (25)
- The Estimation and Use of Absolute Risk for Weighing the Risks and Benefits of Selective Estrogen Receptor Modulators for Preventing Breast Cancer (2001) (25)
- Evaluation of Buccal Cell Samples for Studies of Oral Microbiota (2016) (25)
- Applying the Lorenz curve to disease risk to optimize health benefits under cost constraints. (2009) (25)
- Predicting the absolute risk of dying from colorectal cancer and from other causes using population‐based cancer registry data (2012) (25)
- Helicobacter pylori prevalence and CagA status among children in two counties of China with high and low risks of gastric cancer. (2001) (25)
- Analyzing bivariate continuous data grouped into categories defined by empirical quantiles of marginal distributions. (1997) (25)
- Efficient Adaptively Weighted Analysis of Secondary Phenotypes in Case-Control Genome-Wide Association Studies (2012) (24)
- Beta‐diversity metrics of the upper digestive tract microbiome are associated with body mass index (2015) (24)
- Garlic, Vitamin, and Antibiotic Treatment for Helicobacter pylori: A Randomized Factorial Controlled Trial (2007) (24)
- Risk Assessment and Evaluation of Predictions (2013) (24)
- Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities (2012) (24)
- Pseudo‐likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin‐cohort study (2001) (24)
- Comparison of asbestos exposure assessments by next-of-kin respondents, by an occupational hygienist, and by a job-exposure matrix from the National Occupational Hazard Survey. (2005) (23)
- A Scale-Free Goddness-of-Fit Test for the Exponential Distribution Based on the Lorenz Curve (1978) (23)
- Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index–Breast Cancer Association (2015) (23)
- Design choices for observational studies of the effect of exposure on disease incidence (2019) (23)
- Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16–17, 2017 (2018) (22)
- Handbook of Statistical Methods for Case-Control Studies (2018) (22)
- Helicobacter pylori infection in rural China: exposure to domestic animals during childhood and adulthood. (2001) (22)
- Haplotype‐Based Regression Analysis and Inference of Case–Control Studies with Unphased Genotypes and Measurement Errors in Environmental Exposures (2008) (21)
- Evaluation of three retrospective exposure assessment methods. (2003) (20)
- Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia (2013) (20)
- Perspectives on Using Backcalculation to Estimate HIV Prevalence and Project AIDS Incidence (1992) (20)
- Associations between cancer and Parkinson's disease in U.S. elderly adults. (2016) (20)
- Conversations with NIH statisticians: interviews with the pioneers of biostatistics at the United States National Institute of Health (1997) (19)
- Soy Intake is Associated with Increased 2-Hydroxylation and Decreased 16α-Hydroxylation of Estrogens in Asian-American Women (2009) (19)
- Effects of violations of assumptions on likelihood methods for estimating the penetrance of an autosomal dominant mutation from kin-cohort studies (2001) (19)
- Cardiovascular Risk Factors, Mortality, and Overweight—Reply (2008) (18)
- Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study (2014) (18)
- Dissociation of cell motility from cell proliferation in BALB-c-3T3 fibroblasts. (1972) (18)
- Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials. (1985) (18)
- Are hospitals "keeping up with the Joneses"?: Assessing the spatial and temporal diffusion of the surgical robot. (2013) (18)
- A comparison of likelihood-based and marginal estimating equation methods for analysing repeated ordered categorical responses with missing data: application to an intervention trial of vitamin prophylaxis for oesophageal dysplasia. (1994) (18)
- Projecting the incidence of AIDS. (1990) (18)
- Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects (1991) (17)
- Monitoring rules for stopping accrual in comparative survival studies. (1982) (17)
- Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome (2014) (17)
- Estimating the Variance of Disease‐Prevalence Estimates from Population‐Based Registries (2002) (17)
- Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families. (2007) (17)
- Introduction to Cornfield (1951) A Method of Estimating Comparative Rates from Clinical Data. Applications to Cancer of the Lung, Breast, and Cervix (1997) (16)
- 4. Aids Epidemiology: A Quantitative Approach (1995) (16)
- Comparison of two enzyme-linked immunosorbent assay tests for diagnosis of Helicobacter pylori infection in China. (1997) (16)
- A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771. (1994) (16)
- METHODS FOR PROJECTING THE AIDS EPIDEMIC (1987) (16)
- Maximizing DNA yield for epidemiologic studies: no more buffy coats? (2013) (16)
- Weight-associated deaths in the United States. (2007) (15)
- Using a Mixed Effects Model to Estimate Geographic Variation in Cancer Rates (1999) (15)
- Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population. (2009) (15)
- Predicting the Future of Genetic Risk Prediction (2011) (15)
- Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates. (2002) (15)
- Multiple imputation methods for inference on cumulative incidence with missing cause of failure (2011) (14)
- The size and power of tests for no treatment effect in randomized clinical trials when needed covariates are omitted (1985) (14)
- Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones. (1999) (14)
- Introduction. Errors‐in‐variables workshop (1989) (13)
- Power and related statistical properties of conditional likelihood score tests for association studies in nuclear families with parental genotypes. (2005) (13)
- Survival after AIDS diagnosis in a cohort of hemophilia patients. Multicenter Hemophilia Cohort Study. (1997) (12)
- Backcalculation of the number infected with human immunodeficiency virus in Germany. (1994) (12)
- Probability of helicobacter pylori infection based on IgG levels and other covariates using a mixture model. (2000) (12)
- Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels. (2002) (12)
- An approach to estimating exposure-specific rates of breast cancer from a two-stage case-control study within a cohort. (1997) (12)
- Sources of differences in estimates of obesity-associated deaths from first National Health and Nutrition Examination Survey (NHANES I) hazard ratios. (2010) (12)
- A model for projecting cancer incidence and mortality in the presence of prevention, screening, and treatment programs (1986) (12)
- Searching for blood DNA methylation markers of breast cancer risk and early detection. (2013) (11)
- Correcting Bias, or Biased Corrections? (2008) (11)
- Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers (2014) (11)
- Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine. (2018) (11)
- Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies (2008) (11)
- Comparison of approaches for incorporating new information into existing risk prediction models (2017) (11)
- Levels of CD4+ Lymphocytes, Neopterin, and β2-Microglobulin Are Early Predictors of Acquired Immunodeficiency Syndrome (1990) (10)
- Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199). (2019) (9)
- Piecewise exponential survival times and analysis of case‐cohort data (2012) (9)
- Analysis of a Two‐Stage Case–Control Study with Cluster Sampling of Controls: Application to Nonmelanoma Skin Cancer (2000) (9)
- Using standard microbiome reference groups to simplify beta-diversity analyses and facilitate independent validation (2018) (9)
- Choosing Breast Cancer Risk Models: Importance of Independent Validation. (2020) (9)
- A nonparametric analysis of the transmission rate of human immunodeficiency virus from mother to infant. (1994) (9)
- Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women (2019) (9)
- Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV-infected persons--United States, 1992-1994. (1992) (9)
- Ethical dilemmas in continuing a zidovudine trial after early termination of similar trials. (1993) (8)
- The association between the upper digestive tract microbiota by HOMIM and oral health in a population-based study in Linxian, China (2014) (8)
- Design and analysis considerations for combining data from multiple biomarker studies (2018) (8)
- Use of observational data, including surveillance studies, for evaluating AIDS therapies. (1996) (8)
- Re: All-cause mortality in randomized trials of cancer screening. (2002) (8)
- Bias despite masked assessment of clinical outcomes when an outcome is defined as one of several component events. (1991) (8)
- Screening geographic areas for unusual survival experience or stage at diagnosis with application to breast and colon cancer. (1985) (8)
- Models for carcinogenic risk assessment. (1978) (8)
- Associations between A -Tocopherol, B -Carotene, and Retinol and Prostate Cancer Survival (2009) (8)
- Impact of Population Substructure on Trend Tests for Genetic Case–Control Association Studies (2010) (7)
- The oral microbiome and lung cancer risk: An analysis of 3 prospective cohort studies. (2022) (7)
- Weight and mortality. (2006) (7)
- Breast Cancer Relative Hazard Estimates From Case–Control and Cohort Designs With Missing Data on Mammographic Density (2008) (7)
- Using chemometrics and statistics to improve proteomics biomarker discovery. (2006) (7)
- Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer (2004) (7)
- Performance of BCRAT in high-risk patients with breast cancer. (2019) (7)
- A conversation with Nathan Mantel (1997) (7)
- Mixed Quasi-Independent Models for Categorical Data (1972) (6)
- Using multiple risk models with preventive interventions (2012) (6)
- Weight calibration to improve the efficiency of pure risk estimates from case‐control samples nested in a cohort (2019) (6)
- On Mendelian randomization analysis of case‐control study (2019) (6)
- On the robustness to measurement error of tests for exponentiality (1978) (6)
- Sample Size Estimation When Time-to-Event is the Primary Endpoint (1994) (6)
- Using absolute risks to assess the risks and benefits of treatment (2014) (5)
- Abstract CN07-03: Discriminatory accuracy from Single Nucleotide Polymorphisms in models of absolute breast cancer risk (2008) (5)
- Excess false positive rate caused by population stratification and disease rate heterogeneity in case-control association studies (2009) (5)
- COMMENT ON : VALIDATION OF THE GAIL ET AL. MODEL FOR PREDICTING INDIVIDUALBREAST CANCER RISK. AUTHORS' REPLY (1994) (5)
- Comparing the performance of two models (2017) (5)
- Score tests for familial correlation in genotyped‐proband designs (2000) (5)
- On measures of agreement calculated from contingency tables with categories defined by the empirical quantiles of the marginal distributions. (1997) (5)
- Biased estimates of treatment effect in randomized trials (1984) (5)
- Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial (2021) (5)
- Time Lag Effect (2005) (4)
- Power and sample size for multivariate logistic modeling of unmatched case-control studies (2019) (4)
- Statistical Properties of Teng and Risch’s Sibship Type Tests for Detecting an Association between Disease and a Candidate Allele (2002) (4)
- 33 Nonparametric frequentist proposals for monitoring comparative survival studies (1984) (4)
- Perspectives for Consideration in the Development of Microbial Cell Reference Materials (2019) (4)
- Some Biases That May Affect Kin-Cohort Studies for Estimating the Risks from Identified Disease Genes (2004) (4)
- Applications of Personalized Estimates of Absolute Breast Cancer Risk (2013) (4)
- Mammographic density does not differ between unaffectedBRCA1/2mutation carriers and women at low-to-average risk of breast cancer. (2009) (4)
- Response: Re: Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk (2009) (4)
- Early side effects of intrathoracic BCG therapy in patients with stage I squamous cell carcinoma, adenocarcinoma, or large cell lung cancer (1981) (4)
- Value systems for comparing two independent multinomial trials (1974) (4)
- The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology. (2019) (4)
- Tools for Contralateral Prophylactic Mastectomy Decision Making (2022) (3)
- Cardiovascular Risk Factors, Mortality, and Overweight. Authors' reply (2008) (3)
- Some of Nathan Mantel's contributions to epidemiology. (1999) (3)
- Effects of vitamin and mineral supplementation on total and cancer mortality (Linxian General Population Randomised Nutrition Intervention Trial): results from the 25-year post-trial follow-up (2017) (3)
- Population-density and county-level variation in breast cancer mortality rates among white women residing in the Northeastern and Southern United States (2003) (3)
- Bias Toward the Null (2005) (3)
- Value systems for comparing three or more independent multinomial trials (1975) (3)
- Power of Microbiome Beta-Diversity Analyses Based on Standard Reference Samples. (2020) (3)
- Models of Absolute Risk: Interpretation, Estimation, Validation and Application (2008) (3)
- Use of circulating pregnancy-specific beta 1 glycoprotein as a marker in carcinoma of the breast in women. (1982) (3)
- Is the Benign Breast Disease Breast Cancer Model Well Calibrated? (2015) (3)
- Serum Cytokine Analysis in a Positive Chemoprevention Trial: Selenium, Interleukin-2, and an Association with Squamous Preneoplastic Disease (2010) (3)
- Population‐based monitoring of an urban HIV/AIDS epidemic: Magnitude and trends in the District of Columbia (1993) (3)
- Power and Sample Size for Case-Control Studies (2018) (2)
- An efficient design for verifying disease outcome status in large cohorts with rare exposures and low disease rates. (1999) (2)
- Nonparametric procedures for comparing diagnostic tests with paired data (1984) (2)
- Covariate Adjustment and Ranking Methods to Identify Regions with High and Low Mortality Rates (2010) (2)
- Errors-in-variables workshop. (1989) (2)
- Case-control studies with cluster sampling. (1991) (2)
- Bias from Nonresponse (2005) (2)
- Risk of risk-based mammography screening, ages 40 to 49 [4] (multiple letters) (1999) (2)
- Levels of CD4+ lymphocytes, neopterin and ß2-microglobulin are early predictors of AIDS (1990) (2)
- Assessment of risk model performance (2017) (2)
- Age and sex as factors influencing remission duration in African Burkitt's lymphoma. (1982) (2)
- Case–Control Study, Hospital-Based (2005) (2)
- Parametric Methods for Bivariate Quantile‐Partitioned Tables and the Efficiency of Corresponding Nonparametric Methods (1997) (2)
- Accommodating population differences when validating risk prediction models (2022) (2)
- Breast Cancer Risk FromModifiable and Nonmodifiable Risk Factors AmongWhiteWomen in the United States (2016) (2)
- Postoperative mediastinal radiation for cancer of the lung. (1987) (2)
- Cumulative Incidence Ratio (2005) (2)
- Simple examples should not be extrapolated to the US population (2008) (2)
- Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts (2023) (2)
- The Evaluation of Serial Marker Measurements for Monitoring Patients at Risk of Recurrent Cancer: Application to Colorectal Cancer (1986) (2)
- Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study (2021) (2)
- Early zidovudine and survival in HIV infection. (1992) (2)
- Disinfection of endoscopes from Helicobacter pylori-positive subjects: evaluation of the effectiveness of the Chinese Calijing disinfection kit. (2005) (2)
- Bayesian Approaches to Randomized Trails - Discusion (1994) (2)
- Long-term survival among 298 Hodgkin lymphoma (HL) patients who develop breast cancer (BC): A population-based study. (2010) (2)
- Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica (2022) (1)
- Lifetime data analysis. Editorial. (2008) (1)
- Norman Breslow, an architect of modern biostatistics (2007) (1)
- Monitoring clinical trials to terminate accrual (1981) (1)
- Response to “Biased Corrections or Biased About Corrections” (2009) (1)
- Relationships between body mass index, endogenous estrogen levels, and patterns of estrogen metabolism in Asian‐American women (2009) (1)
- Case Series, Case Reports † (2014) (1)
- Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial. (2022) (1)
- RE: Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. Response. (2014) (1)
- Estimating the decision curve and its precision from three study designs (2019) (1)
- Does Cardiac Transplantation Prolong Life (2020) (1)
- Case–Control Study, Population‐Based (2005) (1)
- Case–Control Study, Hospital-Based † (2014) (1)
- Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years (2012) (1)
- Retrospective Study: Definition† (2014) (1)
- Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress? (2000) (1)
- Estimating the Absolute Risk of Disease Associated with Identified Mutations (2009) (1)
- 55 Cancer in korean war navy technicians (2002) (1)
- Bias from Loss to Follow-up (2005) (1)
- Dave Byar's contribution to epidemiology. (1995) (1)
- The authors replied as follows: (2007) (1)
- Cancer-associated serum globulin demonstrated by polyacrylamide gel electrophoresis. (1980) (1)
- Comments and response on the USPSTF recommendation on screening for breast cancer. (2010) (1)
- Estimating Individualized Risk of Breast Cancer (1999) (1)
- Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome (2014) (1)
- Six articles related to risk assessment and prediction based on work presented at the October 12–14, 2011 Conference on Risk Assessment and Evaluation of Predictions in Silver Spring, Maryland. (2013) (1)
- Weight calibration to improve efficiency for estimating pure risks from the additive hazards model with the nested case‐control design (2020) (1)
- A Statistical History of the AIDS Epidemic (1990) (1)
- Thoughts on “AIDS and COVID‐19: A Tale of Two Pandemics and the Role of Statisticians” by Susan S. Ellenberg and Jeffrey S. Morris (2021) (1)
- LETTER TO THE EDITOR Simple examples should not be extrapolated to the US (2008) (1)
- Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study (2012) (1)
- Simplified sample size calculations for prevention trials (1985) (1)
- Case-Control Study, Population Based † (2014) (1)
- Comparative Mortality for Second Cancers in 29,356 Testicular Cancer Survivors and Matched First Cancers (2007) (1)
- Clinical trials: a practical approach: Stuart Pocock John Wiley and Sons, Chichester, New York, Brisbane, Toronto, and Singapore, 1984, 266 pp., $32 (1985) (1)
- AbstractDirect adjusted survival curves for comparing two treatments (1981) (0)
- Bias from Survival in Prevalent Case–Control Studies † (2014) (0)
- Building and updating relative risk models (2017) (0)
- fast.adonis: a computationally efficient non-parametric multivariate analysis of microbiome data for large-scale studies. (2022) (0)
- Disease prevention models of voluntary confidential screening for human immunodefiency virus (HIV) (1990) (0)
- Increasing efficiency and reducing bias when assessing HPV vaccination efficacy by using non-targeted HPV strains. (2022) (0)
- Population‐Based Study (2005) (0)
- Spline Analysis of Biomarker Data Pooled from Multiple Matched/Nested Case–Control Studies (2019) (0)
- Estimating absolute risk by combining case-control or cohort data with disease registry data (2017) (0)
- EDITORIALS Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer (2001) (0)
- Abstract A39: The human oral microbiota and risk of lung cancer: An analysis of three prospective cohort studies (2020) (0)
- Power of the Cochran-Armitage trend test when exposure scores are based on empirical quantiles of exposure (2012) (0)
- Editors' note on the USPSTF recommendation on screening for breast cancer. (2010) (0)
- Assessing risk model calibration with missing covariates. (2021) (0)
- Some of Sam Greenhouse's contributions to statistical methods (2003) (0)
- Correction: Soy Intake Is Associated with Increased 2-Hydroxylation and Decreased 16-Hydroxylation of Estrogens in Asian-American Women (2009) (0)
- Bias from Survival in Prevalent Case–Control Studies (2005) (0)
- Regression models for absolute risk estimated from cohort data (2017) (0)
- Use of clinical trial data to calculate attributable risks (1988) (0)
- New Model Predicts Breast Cancer Risk in African American Women (2007) (0)
- Bias from Exposure Effects on Controls (2005) (0)
- Acknowledgment of Reviewers 2021. (2021) (0)
- Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16–17, 2017 (2018) (0)
- Projecting breast cancer probabilities. Comments. Authors' reply (1990) (0)
- Risk estimates based on genetic variants and family studies (2017) (0)
- Association between tobacco use and the upper gastrointestinal microbiome among Chinese men (2015) (0)
- Prevalence Rate or Ratio (2005) (0)
- Abstract B126: Does adult soy intake influence total estrogen levels and estrogen metabolism patterns? (2008) (0)
- Discussion of "A formal causal interpretation of the case-crossover design" by Zach Shahn, Miguel A. Hernan, and James M. Robins. (2022) (0)
- Cox model inference for relative hazard and pure risk from stratified weight-calibrated case-cohort data (2023) (0)
- Back-calculation models that take treatment into account (1994) (0)
- Reply to L.A. Newman. (2016) (0)
- Comment on ‘Principles of research’ by Jerome Cornfield (2012) (0)
- Responses to Atkins (1994) (0)
- The prediction impact curve is proportional to the proportion of cases followed (letter commenting: J Clin Epidemiol 2016;69:361-363). (2017) (0)
- Toward a Comprehensive, Integrated Framework for Advanced Statistical Analyses of Observational Studies (19w5198) (2019) (0)
- Response:Re: Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women (2008) (0)
- Models of Absolute Risk (2005) (0)
- Abstract 5489: Feasibility study of gut microbiome collection in randomly sampled women: (2012) (0)
- Abstract 3717: Evaluation and comparison of breast cancer risk prediction models for Hispanic and non-Hispanic white women in the Women's Health Initiative (2011) (0)
- Extensions of the Meta-analytic Approach to Surrogate Endpoints (2005) (0)
- The effect of cigarette smoking on the oral and nasal microbiota (2017) (0)
- The Background Review for the USPSTF Recommendation on Screening for Breast Cancer (2010) (0)
- Confidence intervals for the difference between two relative risks (2020) (0)
- All Ireland Social Medicine Meeting Proceedings of the 12th All Ireland Social Medicine Meeting held in Ballyconnell, Co. Cavan, in March 1991 (1991) (0)
- Definitions and basic concepts for survival data in a cohort without covariates (2017) (0)
- Some statistical methods for immunodiagnostic cancer tests. (1990) (0)
- Robustness of risk-based allocation of resources for disease prevention (2020) (0)
- MARVIN ZELEN LEADERSHIP AWARD IN STATISTICAL SCIENCE AWARDEES (2013) (0)
- Analyzing bivariate continuous data that have been grouped into categories defined by sample quantiles of the marginal distributions (1997) (0)
- IN VIVO DISTRIBUTION OF RADIOACTIVE UROKINASE. (1965) (0)
- Statistical Issues in Evaluation of Surrogate Endpoints (2000) (0)
- Practice of Epidemiology Maximizing DNAYield for Epidemiologic Studies : No More Buffy Coats ? (2013) (0)
- Correlative variation in natural populations of cats, mice and men. (1980) (0)
- Population-Based Study † (2014) (0)
- Incidence Density Ratio (2005) (0)
- On the power of two tests for qualitative interaction (1986) (0)
- [Backcalculation of HIV Infection Rates]: Comment (1993) (0)
- Mo1923 - Prospective Cohort Study of the Oral Microbiota and Colorectal Cancer Risk (2018) (0)
- Commentary on Terry et al., 10-Year Performance of Four Models of Breast Cancer Risk: A Validation Study. Lancet Oncol. 2019;20(4):504-17 (2019) (0)
- Predicting AIDS onset for individual patients. (1991) (0)
- BeyondRecreationalPhysicalActivity:ExaminingOccupationaland HouseholdActivity,TransportationActivity,andSedentaryBehavior inRelationtoPostmenopausalBreastCancerRisk (2010) (0)
- Response to Rockhill's letter to the editor (2005) (0)
- Comparing strategies to estimate the association of obesity with mortality via a Markov model (2011) (0)
- In Asian-American Women, Westernization Influences Estrogen Metabolism, but Not Total Endogenous Estrogen Production. (2009) (0)
- INTERPRETIVE STUDY OF KIDNEY TRANSPLANT SURVIVAL DATA (1971) (0)
- Bias from Loss to Follow-up † (2014) (0)
- 85 Association of serum antibodies to the helicobacter pylori caga antigen with precancerous gastric lesions in chinese populations with contrasting gastric cancer rates (2002) (0)
- A Reanalysis of the Stanford Heart Transplant Data: Comment (1983) (0)
- Case Series, Case Reports (2005) (0)
- Abstract A5: A pilot study of circulating and intrabreast tissue estrogen levels among postmenopausal BRCA1/2 mutation‐positive women (2010) (0)
- Nicked-Square Distribution (2006) (0)
- Examining Video Self-Modeling in Promoting Food Acceptance in Children with Autism Spectrum Disorder in a School Setting (2014) (0)
- Applications of Personalized Estimates of Absolute Breast Cancer Risk (2013) (0)
- Factorial designs for randomized trials (1984) (0)
- Empirical Bivariate Quantile‐Partitioned Distribution (2006) (0)
- Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features (2016) (0)
This paper list is powered by the following services:
Other Resources About Mitchell H. Gail
What Schools Are Affiliated With Mitchell H. Gail?
Mitchell H. Gail is affiliated with the following schools: